| Exchange | Trading Currency | Ticker | Listing Date | SEDOL | Net Asset Value (NAV) | Shares Outstanding | Net Assets |
|---|---|---|---|---|---|---|---|
Al recente Fine Mese & Fine Trimestre (31 Dec 2025) | ETF | Indice | Differenza |
|---|---|---|---|
| 1 Anno | 18.86% | 19.35% | -0.49% |
| 3 Anni | -3.04% | -2.53% | -0.51% |
| Dal Lancio | -14.25% | -13.83% | -0.42% |
| Net Assets (%) | Ticker | Name | Country | SEDOL | Market Price | Shares Held | Market Value |
|---|---|---|---|---|---|---|---|
| Settore | Weight (%) | |
|---|---|---|
| Health Care | 100.0 |
| Paese | Weight (%) | |
|---|---|---|
| United States | 82.9 | |
| Netherlands | 4.8 | |
| Germany | 3.5 | |
| Switzerland | 3.3 | |
| Britain | 2.1 | |
| Singapore | 1.8 | |
| China | 1.6 |
| Settore | Weight (%) | |
|---|---|---|
| Pharmaceuticals, Biotechnology & Life Sciences | 91.3 | |
| Health Care Equipment & Services | 8.7 |
| Ritorno sul Capitale | -19.60% | |
| Media ponderata Cap. di mercato | 49,806 M | |
| 2025 | 2026 | |
| Rapporto prezzo/utili | -21.32 | -31.58 |
| Prezzo/Valore contabile | 5.57 | 6.99 |
| Type of Loan Security | USD Cash | Sovereign Debt |
|---|---|---|
| U.S. Equity and Corporate Securities (including ADRs) | 102% | 105% |
| U.S. Treasury Securities | 105% | 105% |
| U.S. Treasury and Agency Securities | 102% | 105% |

Il Global X Genomics & Biotechnology UCITS ETF (GNOM LN) investe in aziende che potenzialmente possono trarre vantaggio da ulteriori progressi nel campo della scienza genomica, come le società coinvolte nell’editing genetico, nel sequenziamento genomico, nella medicina/terapia genetica, nella genomica computazionale e nella biotecnologia.
| Exchange | Valuta Commerciale | Ticker | Data di Lancio | SEDOL | Valore Patrimoniale Netto (NAV) | Azioni in Circolazione | Patrimonio Netto |
|---|---|---|---|---|---|---|---|
| London Stock Exchange | USD | GNOM LN | 04 Nov 2021 | BP49D86 | $8.54 (4.15%) | 2,420,000 | $20,655,980.80 |
| London Stock Exchange | GBP | GNOG LN | 04 Nov 2021 | BP49D97 | -- | -- | -- |
| Borsa Italiana | EUR | GNOM IM | 18 Nov 2021 | BP49DD1 | -- | -- | -- |
| Deutsche Börse Xetra | EUR | GN0M GY | 11 Nov 2021 | BP49DB9 | -- | -- | -- |
| SIX Swiss Exchange | CHF | GNOM SW | 06 Dec 2021 | BP49DC0 | -- | -- | -- |
| Patrimonio Netto (%) | Ticker | Nome | Paese | SEDOL | Prezzo di Mercato ($) | Azioni Detenute | Valore di Mercato ($) |
|---|---|---|---|---|---|---|---|
| 6.37 | ARWR | ARROWHEAD PHARMACEUTICALS IN | US | BYQBFJ8 | 70.81 | 18,575 | 1,315,295.75 |
| 5.62 | GH | GUARDANT HEALTH INC | US | BFXC911 | 112.33 | 10,329 | 1,160,256.57 |
| 5.59 | ILMN | ILLUMINA INC | US | 2613990 | 147.11 | 7,854 | 1,155,401.94 |
| 5.22 | MRNA | MODERNA INC | US | BGSXTS3 | 35.66 | 30,228 | 1,077,930.48 |
| 5.04 | PRAX | PRAXIS PRECISION MEDICINES I | US | BQ721R4 | 272.90 | 3,815 | 1,041,113.50 |
| 4.66 | NTRA | NATERA INC | US | BYQRG48 | 248.74 | 3,872 | 963,121.28 |
| 4.20 | BMRN | BIOMARIN PHARMACEUTICAL INC | US | 2437071 | 60.07 | 14,436 | 867,170.52 |
| 4.07 | VRTX | VERTEX PHARMACEUTICALS INC | US | 2931034 | 468.38 | 1,794 | 840,273.72 |
| 3.82 | TECH | BIO-TECHNE CORP | US | BSHZ3Q0 | 65.28 | 12,073 | 788,125.44 |
| 3.76 | RNA | AVIDITY BIOSCIENCES INC | US | BMWHPY1 | 72.25 | 10,750 | 776,687.50 |